MEDICINOVA, INC.
Income Statement
| Line Item | FY2010 | FY2009 | FY2008 | FY2007 | FY2006 | FY2005 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — |
| Operating Expenses | ||||||
| Research & Development | $9.7M | $10.9M | — | — | — | — |
| SG&A Expense | $8.2M | $10.4M | — | — | — | — |
| Operating Income | $-17.9M | $-21.2M | — | — | — | — |
| Operating Margin | — | — | — | — | — | — |
| Interest Expense | $1.8M | $242.4K | — | — | — | — |
| Pretax Income | $-20.2M | $-20.4M | — | — | — | — |
| Income Tax Expense | $12.7K | $7.0K | — | — | — | — |
| Net Income | $-20.2M | $-20.4M | $-21.9M | $-48.9M | $-35.7M | $-25.7M |
| Net Margin | — | — | — | — | — | — |
| EPS (Basic) | $-1.63 | $-1.68 | — | — | — | — |
| EPS (Diluted) | $-1.63 | $-1.68 | — | — | — | — |
| Shares Outstanding (Basic) | 12.4M | — | — | — | — | — |
| Shares Outstanding (Diluted) | 12.4M | — | — | — | — | — |
| Dividends Per Share | — | — | — | — | — | — |